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lary committee members. METHOD: We addressed the
issue in two steps: First, we developed guiding principles
which should be evidence based, applicable, and credible,
and second, we proposed a method called randomized
clinical trial (RCT)—matched-arm comparison to estab-
lish therapeutic equivalence where the application of the
appropriate statistical tests, as well as the a priori defini-
tion of the clinical meaningfulness of the results is
stressed. RESULTS: The guiding principles stress the fol-
lowing domains with respect to study selection: The liter-
ature search, the definition and comparison of the popu-
lation parameters such as the pathologic condition,
inclusion and exclusion criteria, baseline characteristics,
placebo response, the drugs, the outcome, and issues such
as drug safety, potential of drug-drug interactions and
potential compliance issues. Once appropriate RCTs have
been identified and comparability is established, the pri-
mary endpoints of the two treatment arms of the two
RCTs are compared through statistical equivalence tests
using a priori defined meaningful differences for clinical end-
points. CONCLUSION: The application of the principles
and the RCT-matched-arm comparison should lead deci-
sion-makers to applicable valid decisions based on unbi-
ased results, with accurate, reproducible comparisons
and predictable clinical results.
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OBJECTIVE: Many pivotal clinical trials include an eco-
nomic component. Because of cost and logistic con-
straints, trials are rarely conducted in every nation where
the product will be marketed. For that reason economic
results obtained in one nation (“source”) are often pre-
sented to decision-makers in another nation (“target”).
Information may be seen as more relevant if findings
from the source nation are projected to the target nation.
Study objective was to identify sources of cross-national
variation in the cost of an episode of care, approaches to
adjust variation, and practical problems in trans-national
adaptation of economic clinical trials. RESULTS: We
present a case study based on analysis of economic end-
points from the Donepezil Nordic Family Impact Study.
Through literature review and experience, we identified
four potential components of transnational cost varia-
tion: 1) relative prices for services (i.e. primary care office
visit fee relative to price for chest X-ray), 2) quantity of
resources (i.e. length of stay for similar hospital admis-
sion), 3) inputs to health production (certain procedures/
services are performed in one nation but do not exist in
the other), and 4) patient population (case definition and
patient demographic characteristics). Approaches to ad-
dressing each source of variation include 1) substituting
unit prices of the target country, 2) adjusting observed re-
source quantity to typical treatment pattern of the target
country, 3) replacing selected treatment encounters with
functionally analogous service existing in target country,
and 4) sub-setting original trial cohort to obtain outcomes
in a patient population representative of the target country.
CONCLUSIONS: Adapting a pharmacoeconomic study is
a process of modifying empirical data. The sequence of ad-
justments represents a progressive trade-off between inter-
nal validity (reliance on empirical data) and external validity
(replication of the target country environment). Transpar-
ency enhances credibility of this process by demonstrating
the separate effect of each category of adjustment.
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OBJECTIVE: There are three main aims of this study. (1)
To create a profile of the state of health in the Danish
population.For this purpose we selected three multi-attrib-
ute classification systems: EQ-5D, SF-36 and 15D. The
selection of instruments was based, inter allia, on the
availability of validated Danish versions and on the in-
struments being used internationally. (2) To evaluate the
instruments in terms of their validity and reliability in
measuring a population’s health status. (3) To compare
the instruments in the measurement and evaluation of
health-related quality of life. METHODS: The study is
based on postal questionnaires, performed by a profes-
sional survey institute. A random sample of around 6.000
individuals of the Danish adult population was contacted
by phone, asking whether they would be interested in
completing the questionnaires. Around 5.000 agreed to
participate, and 3.400 responded (a response rate of
68%). The questionnaires contained all three instruments,
including the complete EQ-5D VAS scaling exercise. A
randomized experiment with 6 versions of EQ-5D con-
taining varied wording and response categories was also
embedded in the study. CONCLUSION: This study will
provide a rich data set, the analysis of which should be
an important contribution to the measurement and valu-
ation of health-related quality of life both in Denmark
and in the wider international context. 
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